Benjamin F. Edwards & Company’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $356K | Buy |
1,810
+142
| +9% | +$29.3K | 0.01% | 769 |
|
|
2024
Q1 | $359K | Sell |
1,668
-196
| -11% | -$41.2K | 0.01% | 739 |
|
|
2023
Q4 | $393K | Buy |
1,864
+1,197
| +179% | +$255K | 0.01% | 688 |
|
|
2023
Q3 | $134K | Buy |
667
+1
| +0.2% | +$199 | 0.01% | 824 |
|
|
2023
Q2 | $123K | Buy |
666
+2
| +0.3% | +$370 | ﹤0.01% | 845 |
|
|
2023
Q1 | $127K | Buy |
664
+10
| +2% | +$1.81K | 0.01% | 832 |
|
|
2022
Q4 | $110K | Buy |
654
+2
| +0.3% | +$348 | ﹤0.01% | 874 |
|
|
2022
Q3 | $115K | Buy |
652
+2
| +0.3% | +$395 | 0.01% | 818 |
|
|
2022
Q2 | $133K | Buy |
650
+1
| +0.2% | +$212 | 0.01% | 778 |
|
|
2022
Q1 | $154K | Buy |
649
+6
| +0.9% | +$1.41K | 0.01% | 753 |
|
|
2021
Q4 | $147K | Buy |
643
+300
| +87% | +$66K | 0.01% | 781 |
|
|
2021
Q3 | $66K | Buy |
343
+1
| +0.3% | +$203 | ﹤0.01% | 957 |
|
|
2021
Q2 | $73K | Buy |
342
+2
| +0.6% | +$422 | ﹤0.01% | 934 |
|
|
2021
Q1 | $70K | Buy |
340
+4
| +1% | +$788 | ﹤0.01% | 925 |
|
|
2020
Q4 | $61K | Sell |
336
-98
| -23% | -$16.7K | ﹤0.01% | 916 |
|
|
2020
Q3 | $73K | Sell |
434
-312
| -42% | -$52.6K | ﹤0.01% | 817 |
|
|
2020
Q2 | $121K | Buy |
746
+148
| +25% | +$26.5K | 0.01% | 686 |
|
|
2020
Q1 | $103K | Buy |
598
+122
| +26% | +$24.3K | 0.01% | 683 |
|
|
2019
Q4 | $96K | Buy |
476
+1
| +0.2% | +$205 | 0.01% | 790 |
|
|
2019
Q3 | $100K | Sell |
475
-83
| -15% | -$17.3K | 0.01% | 744 |
|
|
2019
Q2 | $108K | Buy |
558
+85
| +18% | +$15.7K | 0.01% | 684 |
|
|
2019
Q1 | $78K | Buy |
473
+4
| +0.9% | +$707 | 0.01% | 749 |
|
|
2018
Q4 | $88K | Sell |
469
-24
| -5% | -$4.43K | 0.01% | 695 |
|
|
2018
Q3 | $84K | Sell |
493
-24
| -5% | -$4.04K | 0.01% | 726 |
|
|
2018
Q2 | $85K | Buy |
517
+1
| +0.2% | +$163 | 0.01% | 716 |
|
|
2018
Q1 | $83K | Buy |
516
+32
| +7% | +$5.09K | 0.01% | 729 |
|
|
2017
Q4 | $71K | Buy |
484
+1
| +0.2% | +$142 | 0.01% | 729 |
|
|
2017
Q3 | $65K | Buy |
483
+27
| +6% | +$3.41K | 0.01% | 706 |
|
|
2017
Q2 | $57K | Sell |
456
-153
| -25% | -$18.3K | 0.01% | 684 |
|
|
2017
Q1 | $72K | Buy |
609
+445
| +271% | +$53.5K | 0.01% | 605 |
|
|
2016
Q4 | $19K | Buy |
164
+114
| +228% | +$12.7K | ﹤0.01% | 805 |
|
|
2016
Q3 | $5K | Hold |
50
| – | – | ﹤0.01% | 942 |
|
|
2016
Q2 | $5K | Sell |
50
-30
| -38% | -$2.83K | ﹤0.01% | 892 |
|
|
2016
Q1 | $8K | Buy |
80
+30
| +60% | +$2.73K | ﹤0.01% | 839 |
|
|
2015
Q4 | $5K | Sell |
50
-100
| -67% | -$9.41K | ﹤0.01% | 963 |
|
|
2015
Q3 | $14K | Buy |
150
+100
| +200% | +$9.51K | ﹤0.01% | 791 |
|
|
2015
Q2 | $5K | Buy |
+50
| New | +$4.67K | ﹤0.01% | 1027 |
|
Other funds holding CME
Benjamin F. Edwards & Company's CME Position: Q2 2024 in Review
Benjamin F. Edwards & Company increased its CME Group (CME) stake by 8.5% in Q2 2024, buying an estimated $29.3K and bringing the position to 1,810 shares worth $356K. The position accounts for 0.01% of the portfolio, ranked #769.
Benjamin F. Edwards & Company first reported a position in CME in Q2 2015 and has held it in 37 quarters since. The position peaked at $393K in Q4 2023. 1,382 funds tracked by Wall St. Rank hold CME as of Q2 2024.
- Benjamin F. Edwards & Company held 1,810 shares of CME Group worth $356K as of Q2 2024.
- Benjamin F. Edwards & Company bought 142 CME Group shares in Q2 2024, an estimated $29.3K.
- CME Group made up 0.01% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #769 holding.
- Benjamin F. Edwards & Company first reported a position in CME Group in Q2 2015 and has held it in 37 quarters since.
- Benjamin F. Edwards & Company's CME Group position peaked at $393K in Q4 2023.
- 1,382 funds tracked by Wall St. Rank held CME Group as of Q2 2024.
Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.